| View |
|
DR-XY43405
|
Simvastatin
|
Unbranded
|
40 mg
|
Film-Coated Tablet
|
Antihypercholesterolemina
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
17 January 2024
|
19 May 2029
|
| View |
|
DR-XY43406
|
Simvastatin
|
Unbranded
|
20 mg
|
Film-Coated Tablet
|
Antihypercholesterolemina
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
24 January 2024
|
19 May 2029
|
| View |
|
DR-XY43409
|
Ascorbic Acid + Zinc (as sulfate monohydrate)
|
Unbranded
|
500 mg/10 mg
|
Film-coated tablet
|
Vitamin and Mineral
|
Amherst Laboratories Inc.
|
Philippines
|
Renewal
|
17 April 2024
|
18 June 2029
|
| View |
|
DR-XY43410
|
OMEPRAZOLE
|
OMEGUT
|
40mg
|
Powder for Injection (I.V)
|
PROTON PUMP INHIBITOR
|
Popular Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
29 May 2024
|
13 May 2029
|
| View |
|
DR-XY43422
|
Salbutamol (as Sulfate)
|
Vimonzil
|
2mg/5mL
|
Oral Solution
|
Bronchodilator
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
02 January 2024
|
20 May 2029
|
| View |
|
DR-XY43433
|
TOBRAMYCIN + DEXAMETHASONE (AS SODIUM PHOSPHATE)
|
ORBITEX T
|
3mg/1mg permL (0.3%/ 0.1% w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
ANTI-INFECTIVE
|
Popular Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
10 May 2024
|
20 May 2029
|
| View |
|
DR-XY43438
|
Gabapentin
|
Epiven
|
300 mg
|
Capsule
|
Anticonvulsant
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
22 January 2024
|
20 May 2029
|
| View |
|
DR-XY43447
|
Celecoxib
|
Occib
|
200 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
15 February 2024
|
27 May 2029
|
| View |
|
DR-XY43450
|
Celecoxib
|
Occib
|
400 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
05 February 2024
|
29 May 2029
|
| View |
|
DR-XY43451
|
Celecoxib
|
Coxcel
|
400 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
24 January 2024
|
29 May 2029
|
| View |
|
DR-XY43453
|
Multivitamins + Minerals
|
Berocca Performance
|
(see reverse for formulation)
|
Effervescent Tablet
|
Vitamins and Minerals
|
PT. Bayer Indonesia
|
Indonesia
|
Renewal
|
10 March 2024
|
30 May 2029
|
| View |
|
DR-XY43469
|
Thiamine Hydrochloride + Pyridoxine Hydrochloride + Cyanocobalamin
|
Unbranded
|
500 mg/250 mg/1 mg
|
Film-Coated Tablet
|
Vitamin
|
Northfield Laboratories., Inc.
|
Philippines
|
Renewal
|
06 February 2024
|
09 June 2029
|
| View |
|
DR-XY43471
|
Nimodipine
|
Nimopin
|
200mcg/mL (10mg/50mL)
|
Solution For Iv Infusion
|
Calcium Channel Blocker
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
17 April 2024
|
10 June 2029
|
| View |
|
DR-XY43484
|
Clotrimazole + Clindamycin (as phosphate)
|
Vagclr-3
|
200 mg /100 mg
|
Softgel Capsule For Vaginal Use
|
Antifungal/Antibacterial
|
Gelnova Laboratories (India) Pvt. Ltd.
|
India
|
Renewal
|
04 May 2024
|
11 June 2029
|
| View |
|
DR-XY43496
|
Doxofylline
|
Doxofix
|
400 mg
|
Tablet
|
Anti-asthma
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
25 July 2024
|
15 July 2029
|
| View |
|
DR-XY43497
|
Multivitamins + Lysine HCl + Buclizine HCl
|
BUCLISYR
|
(See Reverse)
|
Syrup
|
Appetite Stimulant
|
La Croesus Pharma, Inc.
|
Philippines
|
Renewal
|
10 May 2024
|
23 June 2029
|
| View |
|
DR-XY43500
|
Pregabalin
|
Vexer 75
|
75mg
|
Capsule
|
Anti-epileptic
|
Akums Drugs & Pharmaceuticals Ltd.
|
India
|
Renewal
|
27 October 2023
|
27 June 2029
|
| View |
|
DR-XY43501
|
Tigecycline
|
Imatig
|
50 mg
|
Lyophilized Powder For Intravenous Infusion
|
Antibacterial
|
Gufic Biosciences Ltd
|
India
|
Renewal
|
25 April 2024
|
26 June 2029
|
| View |
|
DR-XY43502
|
Ofloxacin
|
Ofloxen
|
3mg/g (0.3% w/w)
|
Ophthalmic Ointment
|
Antibacterial (Fluoroquinolone)
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
21 May 2024
|
25 June 2029
|
| View |
|
DR-XY43515
|
Piracetam
|
Neuracet
|
200 mg/mL
|
Solution For Injection (Im/Iv)
|
Psychoanaleptic (Other Psychostimulant and Nootropic)
|
Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
25 July 2024
|
10 July 2029
|